Policy

In May 2024, ASHG hosted a fourth year of virtual advocacy meetings with policymakers on Capitol Hill. Over the course of a week, participants in the  2024 cohort of the Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program joined members of past  ACGT  cohorts and members of the  Government and Public Advocacy Committee (GPAC)  in meetings with 15 congressional... Read More

The ASHG Board of Directors met on April 20-21 for its spring meeting in Rockville, MD, to review FY23 program progress and set FY24 goals; review FY23 fiscal performance and approve the FY24 budget; and learn about plans to celebrate ASHG’s 75 years of scientific achievement, among other items. The following overview highlights key discussions.... Read More

The recently released White House Office of Science and Technology Policy (OSTP) report, Bold Goals for U.S. Biotechnology and Biomanufacturing, highlights where insights provided by human genetics and genomics are fundamental for the health biotechnology ecosystem and are critical components of the bioeconomy. This report comes after OSTP solicited public input in a Request for... Read More

November 8 saw a midterm election during which all members of the House of Representatives and one-third of the Senate were up for re-election. Democrats retained control of the Senate and Republicans ultimately won only a narrow majority in the House. This will usher in at least two years of divided government, and experts anticipate... Read More

At the ASHG 2022 Annual Meeting, members of the ASHG Professional Practice and Social Implications Committee (PPSI) followed up on the recently published Guidance on addressing underrepresentation in genetics and genomics research through community engagement. Organized by ASHG and PPSI members Kyle Brothers, MD, PhD, Amy Lemke, PhD, MS, and Maya Sabatello, LLB, PhD, the... Read More